This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma
British Journal of Cancer Open Access 02 November 2004
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Ahmad I, Islam T, Chanan-Khan A et al. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT. Bone Marrow Transplant 2002; 29: 577–580.
Munshi N, Desikan KR, Anaissie E et al. Peripheral blood stem cell collection (PBSC) after CAD+GCSF as part of total therapy II in newly diagnosed multiple myeloma: Influence of thalidomide (THAL) administration. Blood 1999; 94 (Suppl. 1): 578a (Abstr.).
Kroger N, Zeller W, Hassan HT et al. Differences between expression of adhesion molecules on CD34+ cells from bone marrow and GCSF stimulated peripheral blood. Stem Cells 1998; 16: 49–53.
Geitz H, Handt S, Zwingenberger K . Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade. Immunopharmacology 1996; 2–3: 213–221.
Lichterfeld M, Martin S, Burkly L et al. Mobilization of CD34+ haematopoietic stem cells is associated with a functional inactivan of the integrin very late antigen 4. Br J Haematol 2000; 110: 71–81.
Zangari M, Anaissie E, Desikan R et al. Thalidomide-induced hypercoagulability in multiple myeloma (MM). Blood 2000; 96 (Suppl. 1): 5024 (Abstr.).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pitini, V., Arrigo, C., Aloi, G. et al. Thalidomide as salvage therapy for VAD-refractory multiple myeloma prior to autologous PBSCT. Bone Marrow Transplant 31, 1065 (2003). https://doi.org/10.1038/sj.bmt.1704079
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704079
This article is cited by
-
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield
Leukemia (2007)
-
An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma
British Journal of Cancer (2004)